Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJp Morg.chin Regulatory News (JCGI)

Share Price Information for Jp Morg.chin (JCGI)

Share Price is delayed by 15 minutes
Get Live Data
284.50    -3.50 (-1.22%)
Bid:
284.00
Ask:
284.50
Spread: 0.50 (0.176%)
Market Cap: £229.81m
JCGI Live PriceLast checked at - London Stock Exchange

Intraday Jp Morg.chin Share Chart

Kepler Trust Intelligence: New Research

16 Jan 2026 07:00

RNS Number : 1146P
JPMorgan China Growth & Income PLC
16 January 2026
 

JPMorgan China Growth & Income: New Research

16/01/2026

Invests in high-quality Chinese companies exposed to the country's long-term structural themes.

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGPUMPGUPQGCA
Date   Source Headline
24th Jan 20253:17 pmRNSDirector/PDMR Shareholding
24th Jan 202510:22 amRNSNet Asset Value(s)
23rd Jan 20255:01 pmRNSResult of AGM
23rd Jan 20255:01 pmRNSDirectorate Change
23rd Jan 20253:53 pmRNSHolding(s) in Company
23rd Jan 202510:51 amRNSNet Asset Value(s)
22nd Jan 202510:44 amRNSNet Asset Value(s)
21st Jan 202510:39 amRNSNet Asset Value(s)
20th Jan 202512:11 pmRNSGearing announcement
20th Jan 202511:28 amRNSNet Asset Value(s)
17th Jan 202510:40 amRNSNet Asset Value(s)
16th Jan 202510:27 amRNSNet Asset Value(s)
15th Jan 202510:20 amRNSNet Asset Value(s)
14th Jan 202510:49 amRNSNet Asset Value(s)
13th Jan 202511:53 amRNSGearing announcement
13th Jan 202510:41 amRNSNet Asset Value(s)
10th Jan 202511:16 amRNSNet Asset Value(s)
10th Jan 20259:48 amRNSTen Largest Investments
9th Jan 202510:50 amRNSNet Asset Value(s)
8th Jan 202510:48 amRNSNet Asset Value(s)
7th Jan 202510:46 amRNSNet Asset Value(s)
6th Jan 202512:07 pmRNSGearing announcement
6th Jan 202510:56 amRNSNet Asset Value(s)
6th Jan 202510:45 amRNSDirectorate Change
3rd Jan 202511:23 amRNSDividend Declaration - Replacement
3rd Jan 202510:57 amRNSNet Asset Value(s)
2nd Jan 20253:26 pmRNSDividend Declaration
2nd Jan 202512:02 pmRNSNet Asset Value(s)
31st Dec 202410:21 amRNSNet Asset Value(s)
30th Dec 202411:40 amRNSGearing Announcement
30th Dec 202411:08 amRNSNet Asset Value(s)
27th Dec 202412:40 pmRNSBlock listing Interim Review
27th Dec 202411:59 amRNSNet Asset Value(s)
24th Dec 202410:37 amRNSNet Asset Value(s)
23rd Dec 202411:18 amRNSGearing announcement
23rd Dec 202410:41 amRNSNet Asset Value(s)
20th Dec 202411:42 amRNSNet Asset Value(s)
19th Dec 202410:43 amRNSNet Asset Value(s)
18th Dec 202410:48 amRNSNet Asset Value(s)
17th Dec 202410:57 amRNSNet Asset Value(s)
16th Dec 202411:35 amRNSGearing announcement
16th Dec 202410:57 amRNSNet Asset Value(s)
13th Dec 202410:51 amRNSNet Asset Value(s)
12th Dec 202410:21 amRNSNet Asset Value(s)
11th Dec 20243:21 pmRNSTen Largest Investments
11th Dec 202411:10 amRNSNet Asset Value(s)
10th Dec 202410:43 amRNSNet Asset Value(s)
9th Dec 20244:30 pmRNSFinal Results
9th Dec 202412:17 pmRNSGearing Announcement
9th Dec 202410:43 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.